These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 15689835)

  • 21. [Transdermal administration of drugs].
    Merkus FW
    Ned Tijdschr Geneeskd; 1986 Dec; 130(51):2291-2. PubMed ID: 3821946
    [No Abstract]   [Full Text] [Related]  

  • 22. Penetration properties and safety aspects of topically applied products.
    Fluhr J; Lademann J
    Skin Pharmacol Physiol; 2008; 21(6):293. PubMed ID: 18997482
    [No Abstract]   [Full Text] [Related]  

  • 23. [Simple skin tests in the initial evaluation of the tolerance of a topical medication or cosmetic].
    Assier-Bonnet H; Revuz J
    Ann Dermatol Venereol; 1998 Dec; 125(12):916-8. PubMed ID: 9922869
    [No Abstract]   [Full Text] [Related]  

  • 24. Some metal-backed drug patches lack warning about MRI burn risk.
    J Am Vet Med Assoc; 2009 Jul; 235(1):16. PubMed ID: 19623751
    [No Abstract]   [Full Text] [Related]  

  • 25. [The 1990 reports on adverse effects--a review. Skin adverse effects still dominate. A study on hemorrhage in connection with anticoagulant therapy].
    Lakartidningen; 1991 Jul; 88(28-29):2468-70. PubMed ID: 1830356
    [No Abstract]   [Full Text] [Related]  

  • 26. Skin permeation: the years of enlightenment.
    Hadgraft J; Lane ME
    Int J Pharm; 2005 Nov; 305(1-2):2-12. PubMed ID: 16246513
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug hypersensitivity in the age of electronic medical records.
    Young AL; Marji J; Grossman ME
    J Drugs Dermatol; 2011 Dec; 10(12):1430-1. PubMed ID: 22134567
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transdermal Patches: Considerations in Special Populations.
    Hurley C; Semancik L
    Conn Med; 2016 Jan; 80(1):39-42. PubMed ID: 26882791
    [No Abstract]   [Full Text] [Related]  

  • 29. Fixed drug eruption (FDE): changing scenario of incriminating drugs.
    Sehgal VN; Srivastava G
    Int J Dermatol; 2006 Aug; 45(8):897-908. PubMed ID: 16911371
    [No Abstract]   [Full Text] [Related]  

  • 30. Fixed drug reaction may be sexually induced.
    Zawar V; Chuh A
    Int J Dermatol; 2006 Aug; 45(8):1003-4; author reply 1004. PubMed ID: 16911407
    [No Abstract]   [Full Text] [Related]  

  • 31. Transdermal drug delivery system (TDDS) adhesion as a critical safety, efficacy and quality attribute.
    Wokovich AM; Prodduturi S; Doub WH; Hussain AS; Buhse LF
    Eur J Pharm Biopharm; 2006 Aug; 64(1):1-8. PubMed ID: 16797171
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vesicles as tools for the modulation of skin permeability.
    Dubey V; Mishra D; Nahar M; Jain NK
    Expert Opin Drug Deliv; 2007 Nov; 4(6):579-93. PubMed ID: 17970662
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transdermal and topical pharmacotherapy for male sexual dysfunction.
    Ohebshalom M; Mulhall JP
    Expert Opin Drug Deliv; 2005 Jan; 2(1):115-20. PubMed ID: 16296739
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transdermal drug patches: medicine with muscle.
    Schulmeister L
    Nursing; 2005 Jan; 35(1):48-52. PubMed ID: 15622207
    [No Abstract]   [Full Text] [Related]  

  • 35. Using transdermal medication patches.
    McConnell EA
    Nursing; 1997 Jul; 27(7):18. PubMed ID: 9275759
    [No Abstract]   [Full Text] [Related]  

  • 36. Transdermal drug delivery using ultrasound-theory, understanding and critical analysis.
    Sivakumar M; Tachibana K; Pandit AB; Yasui K; Tuziuti T; Towata A; Iida Y
    Cell Mol Biol (Noisy-le-grand); 2005 Sep; 51 Suppl():OL767-84. PubMed ID: 16171576
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Transdermal drug administration].
    Sewing KF
    Dtsch Med Wochenschr; 1982 Apr; 107(16):603-4. PubMed ID: 7067643
    [No Abstract]   [Full Text] [Related]  

  • 38. Giving partial doses of transdermal patches.
    Lee HA; Anderson PO
    Am J Health Syst Pharm; 1997 Aug; 54(15):1759-60. PubMed ID: 9262751
    [No Abstract]   [Full Text] [Related]  

  • 39. Vesicular carriers for dermal drug delivery.
    Sinico C; Fadda AM
    Expert Opin Drug Deliv; 2009 Aug; 6(8):813-25. PubMed ID: 19569979
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Randomised crossover comparison of skin irritation with two transdermal oestradiol patches.
    Ross D; Rees M; Godfree V; Cooper A; Hart D; Kingsland C; Whitehead M
    BMJ; 1997 Aug; 315(7103):288. PubMed ID: 9274549
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.